Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 6Unknown 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Genitourinary 4Thoracic 3Head & Neck 3Breast 3NET 2Lymphoid 2Gynecologic 2Endocrine 2CNS 2Other hematologic neoplasm 1

Conditions

Neuroendocrine Tumors 2Disease 1

Interventions

lutetium Lu 177 dotatate 6Everolimus 6lanreotide 5anlotinib 5Temozolomide 5Injections 4Dexmedetomidine 4Cisplatin 4surufatinib 3Thyrotropin Alfa 3Sodium Chloride 3Saline Solution 3Fluorodeoxyglucose F18 3Blood Specimen Collection 3177Lu-octreotide, DOTA(0)-Tyr(3)- 3(177)Lu-DOTA-EB-TATE 3sintilimab 2penpulimab 2cabozantinib 2Surgical Procedures, Operative 2Sorafenib 2Rosiglitazone 2Radiotherapy 2Radiofrequency Ablation 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Nivolumab 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Metformin 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Positron Emission Tomography Computed Tomography × Endocrine × Clear all
NCT03511768 2018-04-30

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Xiangya Hospital of Central South University

Phase 1/2 Unknown
65 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02621541 2016-01-06

Nonfunctional Pancreatic NET and PET Imaging

Turku University Hospital

Phase 4 Unknown
20 enrolled
EndocrineNET

Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡